Crossmark

Deep learning-based CT radiomics predicts prognosis of unresectable hepatocellular carcinoma treated with TACE-HAIC combined with PD-1 inhibitors and tyrosine kinase inhibitors

Crossref DOI link: https://doi.org/10.1186/s12876-024-03555-7

Published Online: 2025-01-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yin, Linan

Liu, Ruibao

Li, Wei

Li, Shijie

Hou, Xunbo
License Information

Text and Data Mining valid from 2025-01-21

Version of Record valid from 2025-01-21
More Information

Article History

Received: 31 July 2024

Accepted: 9 December 2024

First Online: 21 January 2025

Declarations

:

: Approval for the study was obtained from the Ethics Committee of Harbin Medical University Cancer Hospital (Ethics number: 2023-281-IIT). Written informed consent was not required due to the retrospective nature of the study, and the need for consent to participate was also waived by the ethics committee.

: Not Applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below